COMP <GO>
IRLA vs XFOR // EV/EBITDA & P/E VALUATION
IRulya Therapeutics Inc. (NASDAQ) VS. X4 Pharmaceuticals Inc. (NASDAQ) • 15-METRIC TALLY: IRLA 1
— XFOR 2
■ METRIC PARITY
LAST: $31.62 (-4.05%) • MKT CAP: $342.8M
valuation
—
LAST: $3.36 (+0.30%) • MKT CAP: $333.1M
valuation
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (IRLA VS. XFOR)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | IRLA | XFOR | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | 83.60% | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | -35.00% | 0.00 | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | -12.19% | — | — | TIE | /fcf-yield <GO> |
| Operating Margin | — | -60.00% | — | TIE | /operating-margins <GO> |
| Net Profit Margin | — | -60.00% | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | — | 180.00% | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | 0.20 | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 1/9 | 3/9 | -2.00 | XFOR | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 52.5 | 60.3 | -7.80 | XFOR | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $342.8M | $333.1M | $9.7M | IRLA | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | IRLA REV | XFOR REV | IRLA GROSS % | XFOR GROSS % | IRLA FCF | XFOR FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $0 | $35.1M | — | 83.6% | -$41.8M | -$85.6M |
| FY 2024 | $0 | $2.6M | — | 68.8% | -$32.2M | -$131.2M |
| FY 2023 | $0 | $0 | — | — | -$18.3M | -$96.5M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
IRLA // BETA —
XFOR // BETA —